Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for future freshmen who will enroll for the 2026/2027 academic year.If you are already enrolled in this course of study, consult the information available on the course page:
Combined Bachelor's + Master's degree in Pharmacy - Enrollment until 2025/2026The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
2° Year It will be activated in the A.Y. 2027/2028
| Modules | Credits | TAF | SSD |
|---|
3° Year It will be activated in the A.Y. 2028/2029
| Modules | Credits | TAF | SSD |
|---|
4° Year It will be activated in the A.Y. 2029/2030
| Modules | Credits | TAF | SSD |
|---|
5° Year It will be activated in the A.Y. 2030/2031
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
Legend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Emerging and re-emerging infectious diseases (It will be activated in the A.Y. 2028/2029)
Teaching code
4S011784
Credits
3
Scientific Disciplinary Sector (SSD)
MEDS-10/B - Malattie infettive
Learning objectives
At the end of the course the student will be able to:
• Understand the epidemiology (risk and mode of transmission), clinical picture, and preventive options of
main emerging and re-emerging infectious diseases at global level with particular focus at national level
• Integrate this knowledge with the development of a clinical infectious disease research protocol
• Evaluate the quality of scientific evidence in the field of emerging infectious diseases
• Understand the basic therapeutic measures in the field of infectious diseases